GlassScriptPhysician profile
John W Pierpont
NPI 1285689729
$7,690.34
in general payments reported to CMS, 2019-2025
45 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $699 · 2021: $1,168 · 2022: $1,150 · 2023: $1,242 · 2024: $1,253 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,837 · Education: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,836.74 |
| Education | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,349.54 | 2019-2025 | |
| Ucb, INC. | $827.87 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Abbvie INC. | $599.02 | 2019-2025 | |
| Biogen, INC. | $480.62 | 2019-2025 | Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $427.08 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Amneal Pharmaceuticals LLC | $372.39 | 2019-2025 | Rytary, Ongentys, Ongentys 50mg Capsules 30 |
| Lilly USA, LLC | $334.04 | 2019-2025 | Emgality, Kisunla, Reyvow |
| Eisai INC. | $266.99 | 2023-2025 | |
| Medtronic, INC. | $250.45 | 2021-2025 | Sensight, Percept PC Brainsense |
| Amgen INC. | $247.00 | 2019-2025 | Uplizna |
| Argenx US, INC. | $215.85 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Boston Scientific Corporation | $176.35 | 2020-2023 | |
| Biohaven Pharmaceuticals, INC. | $148.65 | 2021 | |
| Pfizer INC. | $145.40 | 2023-2025 | |
| Horizon Therapeutics Plc | $135.09 | 2021-2023 | Uplizna |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pierpont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.